{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-224202","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2022-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.099061+00:00","generated_at":"2026-06-23T22:43:43.022753+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Halozyme issues $720M 1.00% convertible notes due 2028; repays term loan, buys back shares","bullets":["Issued $720M in 1.00% Convertible Senior Notes due 2028, including $95M from over-allotment option.","Net proceeds ~$701.4M; used to repay $250M term loan, exchange $77.6M of existing notes, and repurchase $90M of common stock.","Initial conversion price ~$56.02 per share; capped call transactions limit dilution with cap price $75.4075.","Increased 2022 stock repurchase authorization to $200M (from $100M) to commence after offering close.","Capped call transactions entered with multiple counterparties to reduce dilution upon conversion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-224202","json":"https://secwatch.observer/filing/0001193125-22-224202.json","markdown":"https://secwatch.observer/filing/0001193125-22-224202.md","text":"https://secwatch.observer/filing/0001193125-22-224202.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000119312522224202/0001193125-22-224202-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000119312522224202/d391138d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:43:43.022753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}